HER-2

3 registered clinical trials studyying HER-2.

Status	Trial	Sponsor	Phase
Unknown	Assessing Her2/Neu Expression in Gastric Cancer With Dual or Multiple Tumor Tissue Paraffin Blocks NCT02852096	Shanghai Zhongshan Hospital	N/A
Completed	Treatment With BIBW 2992, Irreversible Inhibitor of EGFR and HER-2 in Non-small Cell Lung Cancer NCT01542437	Instituto Nacional de Cancerologia de Mexico	Phase 2
Completed	Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy NCT00897299	Eastern Cooperative Oncology Group	—